StreetInsider.com News Articles

Form SCHEDULE 13G GERON CORP Filed by: Soleus Capital Master Fund, L.P.

Tue, 03 Mar 2026 16:33:00 -0500

si-local-file:///var/storage/secattach/20260303/26102175.html

Form SCHEDULE 13G GERON CORP Filed by: Soleus Capital Master Fund, L.P.

Tue, 03 Mar 2026 16:33:00 -0500

si-local-file:///var/storage/secattach/20260303/26102175.html

Form S-3ASR GERON CORP

Mon, 02 Mar 2026 07:48:00 -0500

si-local-file:///var/storage/secattach/20260302/26087116.html

Form S-3ASR GERON CORP

Mon, 02 Mar 2026 07:48:00 -0500

si-local-file:///var/storage/secattach/20260302/26087116.html

Form 10-K GERON CORP For: Dec 31

Mon, 02 Mar 2026 07:11:00 -0500

http://archive.fast-edgar.com/20260302/ANVZD222Z22NB2Z2222P22Z9NPBMZZ22AK82

Filed on: March 2, 2026

Form 10-K GERON CORP For: Dec 31

Mon, 02 Mar 2026 07:11:00 -0500

http://archive.fast-edgar.com/20260302/ANVZD222Z22NB2Z2222P22Z9NPBMZZ22AK82

Filed on: March 2, 2026

Form 8-K GERON CORP For: Feb 25

Wed, 25 Feb 2026 07:15:00 -0500

si-local-file:///var/storage/secattach/20260225/26055246.html

Form 8-K GERON CORP For: Feb 25

Wed, 25 Feb 2026 07:15:00 -0500

si-local-file:///var/storage/secattach/20260225/26055246.html

Geron Corp (GERN) Misses Q4 EPS by 2c

Wed, 25 Feb 2026 07:03:32 -0500

Geron Corp (NASDAQ: GERN) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $48.02 million versus the consensus estimate of $50.76 million.

For earnings history and earnings-related data on Geron Corp (GERN) click here.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.

Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Wed, 25 Feb 2026 07:00:00 -0500

Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively

Reported total operating expenses of $255 million for full year 2025, within the previous guidance range

Reiterated 2026 RYTELO net product revenue and total operating expenses expected in the ranges of $220 million to $240 million, and $230 million to $240 million, respectively

Ended 2025 with cash, cash equivalents, restricted cash and marketable securities of roughly $401 million

Company to host conference call and webcast today, February 25, at 8:00 a.m.